Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS guidance · 2024-03-15Clinical Trial Update: Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction [Phase 4]
Clinical trial update on reduced antithrombotic strategy for high bleeding risk myocardial infarction patients in a Phase 4 study.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Computed Tomography Coronary Angiogram (CTCA) Versus Traditional Care in Emergency Department Assessment of Potential Acute Coronary Syndromes (ACS) [NA]
Completed clinical trial comparing CT coronary angiography to traditional care in emergency department assessment of potential acute coronar…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART) [Phase 4]
Phase 4 clinical trial update investigating decreased usage of beta-blockers after myocardial infarction in the SWEDEHEART registry.
-
EMA approval · 2024-02-29EMA Authorised: Clopidogrel Teva (hydrogen sulphate) (clopidogrel (as hydrogen sulfate)) — Teva Pharma B.V.
EMA authorised Clopidogrel Teva (hydrogen sulphate) for multiple cardiovascular indications including acute coronary syndrome, myocardial in…
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES [Phase 4]
Phase 4 clinical trial comparing personalized versus standard duration of dual antiplatelet therapy and comparing new-generation polymer-fre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome [Phase 2]
Phase 2 trial comparing 30 mg vs 75 mg aspirin dosing in elderly patients after acute coronary syndrome, investigating effects in myocardial…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Disrupt CAD III Post-Approval Study (PAS)
Post-approval study update for Disrupt CAD III; completed with results posted in February 2024.
-
FDA approval · 2024-01-22FDA Approved: VALSARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application from Unichem Pharmaceuticals (USA), Inc. for valsartan (generic valsartan) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Improve SCA Bridge Study
Clinical trial update for the Improve SCA Bridge Study completed with results posted in 2024.
-
FDA approval · 2024-01-05FDA Approved: TNKASE — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for TNKASE (tenecteplase) from Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: Iron in Patients With Cardiovascular Disease [Phase 3]
Phase 3 clinical trial for iron treatment in cardiovascular disease patients was terminated.
-
FDA approval · 2023-12-22FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approves a supplemental application for Tenormin (atenolol) filed by Almatica Pharma LLC.
-
EMA approval · 2023-12-19EMA Authorised: Clopidogrel Taw Pharma (previously Clopidogrel Mylan) (clopidogrel hydrochloride) — Taw Pharma (Ireland) Limited
EMA authorised a clopidogrel product (clopidogrel hydrochloride) by Taw Pharma (Ireland) Limited for peripheral vascular diseases, stroke, m…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? [Phase 4]
Phase 4 clinical trial update investigating the optimal antithrombotic strategy for patients with atrial fibrillation undergoing PCI.
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Beta Blocker Interruption After Uncomplicated Myocardial Infarction [Phase 4]
Clinical trial update from a Phase 4 study evaluating interruption of beta-blocker therapy after uncomplicated myocardial infarction.
-
FDA approval · 2023-11-22FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for metoprolol tartrate from Aurobindo Pharma Limited. The action confirms approval of changes to an…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) [Phase 3]
A Phase 3 clinical trial update for pexelizumab in conjunction with angioplasty in acute myocardial infarction (APEX-AMI) has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI) [Phase 3]
Phase 3 clinical trial assessing whether vitamin D impacts ventricular remodeling after acute myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients [Phase 4]
A Phase 4 clinical trial update investigating differential effects of dual antiplatelet and dual antithrombotic therapy on hemostasis in chr…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT) [NA]
Clinical trial evaluating intracoronary hyperoxemic oxygen therapy in patients with anterior wall acute myocardial infarction has completed;…
-
FDA approval · 2023-09-07FDA Approved: CLOPIDOGREL — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) by Apotex Corp., under the ANDA, authorizing a modif…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization [Phase 4]
Phase 4 trial update on pre-hospital thrombolytic therapy followed by urgent culprit artery revascularization for myocardial infarction.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Preventive VT Substrate Ablation in Ischemic Heart Disease [Phase 3]
Phase 3 clinical trial update on preventive substrate ablation for ventricular tachycardia in ischemic heart disease (status: unknown).
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography [Phase 3]
Phase 3 trial updates on dapagliflozin examining effects on coronary calcium and epicardial fat using Cardio tomography.
-
CLINICAL_TRIALS trial_result · 2023-08-02Clinical Trial Update: Look AHEAD: Action for Health in Diabetes [NA]
Clinical trial update for Look AHEAD study (diabetes and cardiovascular risk factors) with completed status and results posted.